The global Ghrelin market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Ghrelin is a polypeptide hormone secreted by G cells in the stomach. It mainly stimulates appetite and promotes the release of growth hormone. It is often referred to as the "ghrelin" because its levels rise significantly during states of hunger, prompting individuals to feel hungry and eat more. By binding to the ghrelin receptor in the hypothalamus, it promotes appetite, regulates energy metabolism, and stimulates the secretion of growth hormone. In addition, it is also involved in various physiological processes such as gastrointestinal motility and insulin regulation.

From a downstream perspective, Obesity and Weight Management accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Ghrelin leading manufacturers including Bio-Techne, Isca Biochemicals, Elabscience Bionovation Inc, Life Science Group, BioCrick, CPC Scientific Inc, Bachem, Merck KGaA, GenScript, Kaneka Corporation(Eurogentec), etc., dominate supply; the top five capture approximately % of global revenue, with Bio-Techne leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Ghrelin market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Ghrelin Market Report

Report Metric	Details
Report Name	Ghrelin Market
Segment by Type	Mouse Rat Human
Segment by Application	Obesity and Weight Management Gastrointestinal Diseases Neuroprotection Other
Production by Region	North America Europe China Japan
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bio-Techne, Isca Biochemicals, Elabscience Bionovation Inc, Life Science Group, BioCrick, CPC Scientific Inc, Bachem, Merck KGaA, GenScript, Kaneka Corporation(Eurogentec), Biorbyt, Creative Diagnostics, AAPPTec, LLC, Cayman Chemical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Ghrelin study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Ghrelin Market report?

Ans: The main players in the Ghrelin Market are Bio-Techne, Isca Biochemicals, Elabscience Bionovation Inc, Life Science Group, BioCrick, CPC Scientific Inc, Bachem, Merck KGaA, GenScript, Kaneka Corporation(Eurogentec), Biorbyt, Creative Diagnostics, AAPPTec, LLC, Cayman Chemical

What are the Application segmentation covered in the Ghrelin Market report?

Ans: The Applications covered in the Ghrelin Market report are Obesity and Weight Management, Gastrointestinal Diseases, Neuroprotection, Other

What are the Type segmentation covered in the Ghrelin Market report?

Ans: The Types covered in the Ghrelin Market report are Mouse, Rat, Human

1 Study Coverage

1.1 Introduction to Ghrelin: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Ghrelin Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Mouse

1.2.3 Rat

1.2.4 Human

1.3 Market Segmentation by Application

1.3.1 Global Ghrelin Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Obesity and Weight Management

1.3.3 Gastrointestinal Diseases

1.3.4 Neuroprotection

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Ghrelin Revenue Estimates and Forecasts 2020-2031

2.2 Global Ghrelin Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Ghrelin Sales Estimates and Forecasts 2020-2031

2.4 Global Ghrelin Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Global Production Analysis

3.1 Global Ghrelin Production Capacity and Utilization Rates (2020–2031)

3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)

3.3 Regional Production Dynamics

3.3.1 Historic Production by Region (2020-2025)

3.3.2 Forecasted Production by Region (2026-2031)

3.3.3 Production Market Share by Region (2020-2031)

3.3.4 Regulatory and Trade Policy Impact on Production

3.3.5 Production Capacity Enablers and Constraints

3.4 Key Regional Production Hubs

3.4.1 North America

3.4.2 Europe

3.4.3 China

3.4.4 Japan

4 Competition by Manufacturers

4.1 Global Ghrelin Sales by Manufacturers

4.1.1 Global Sales Volume by Manufacturers (2020-2025)

4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

4.2 Global Ghrelin Manufacturer Revenue Rankings and Tiers

4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

4.3 Manufacturer Profitability Profiles and Pricing Strategies

4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

4.3.2 Manufacturer-Level Price Trends (2020-2025)

4.4 Key Manufacturers Manufacturing Base and Headquarters

4.5 Main Product Type Market Size by Manufacturers

4.5.1 Mouse Market Size by Manufacturers

4.5.2 Rat Market Size by Manufacturers

4.5.3 Human Market Size by Manufacturers

4.6 Global Ghrelin Market Concentration and Dynamics

4.6.1 Global Market Concentration (CR5 and HHI)

4.6.2 Entrant/Exit Impact Analysis

4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

5 Global Product Segmentation Analysis

5.1 Global Ghrelin Sales Performance by Type

5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

5.1.2 Global Sales Market Share by Type (2020-2031)

5.2 Global Ghrelin Revenue Trends by Type

5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

5.2.2 Global Revenue Market Share by Type (2020-2031)

5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

5.4 Product Technology Differentiation

5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

5.5.1 High-Growth Niches and Adoption Drivers

5.5.2 Profitability Hotspots and Cost Drivers

5.5.3 Substitution Threats

6 Global Downstream Application Analysis

6.1 Global Ghrelin Sales by Application

6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

6.1.2 Global Sales Market Share by Application (2020-2031)

6.1.3 High-Growth Application Identification

6.1.4 Emerging Application Case Studies

6.2 Global Ghrelin Revenue by Application

6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

6.2.2 Revenue Market Share by Application (2020-2031)

6.3 Global Pricing Dynamics by Application (2020-2031)

6.4 Downstream Customer Analysis

6.4.1 Top Customers by Region

6.4.2 Top Customers by Application

7 North America

7.1 North America Sales Volume and Revenue (2020-2031)

7.2 North America Key Manufacturers Sales Revenue in 2024

7.3 North America Ghrelin Sales and Revenue by Type (2020-2031)

7.4 North America Ghrelin Sales and Revenue by Application (2020-2031)

7.5 North America Growth Accelerators and Market Barriers

7.6 North America Ghrelin Market Size by Country

7.6.1 North America Revenue by Country

7.6.2 North America Sales Trends by Country

7.6.3 US

7.6.4 Canada

7.6.5 Mexico

8 Europe

8.1 Europe Sales Volume and Revenue (2020-2031)

8.2 Europe Key Manufacturers Sales Revenue in 2024

8.3 Europe Ghrelin Sales and Revenue by Type (2020-2031)

8.4 Europe Ghrelin Sales and Revenue by Application (2020-2031)

8.5 Europe Growth Accelerators and Market Barriers

8.6 Europe Ghrelin Market Size by Country

8.6.1 Europe Revenue by Country

8.6.2 Europe Sales Trends by Country

8.6.3 Germany

8.6.4 France

8.6.5 U.K.

8.6.6 Italy

8.6.7 Russia

9 Asia-Pacific

9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

9.3 Asia-Pacific Ghrelin Sales and Revenue by Type (2020-2031)

9.4 Asia-Pacific Ghrelin Sales and Revenue by Application (2020-2031)

9.5 Asia-Pacific Ghrelin Market Size by Region

9.5.1 Asia-Pacific Revenue by Region

9.5.2 Asia-Pacific Sales Trends by Region

9.6 Asia-Pacific Growth Accelerators and Market Barriers

9.7 Southeast Asia

9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand

9.8 China

9.9 Japan

9.10 South Korea

9.11 China Taiwan

9.12 India

10 Central and South America

10.1 Central and South America Sales Volume and Revenue (2020-2031)

10.2 Central and South America Key Manufacturers Sales Revenue in 2024

10.3 Central and South America Ghrelin Sales and Revenue by Type (2020-2031)

10.4 Central and South America Ghrelin Sales and Revenue by Application (2020-2031)

10.5 Central and South America Investment Opportunities and Key Challenges

10.6 Central and South America Ghrelin Market Size by Country

10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 Brazil

10.6.3 Argentina

11 Middle East and Africa

11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

11.3 Middle East and Africa Ghrelin Sales and Revenue by Type (2020-2031)

11.4 Middle East and Africa Ghrelin Sales and Revenue by Application (2020-2031)

11.5 Middle East and Africa Investment Opportunities and Key Challenges

11.6 Middle East and Africa Ghrelin Market Size by Country

11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

11.6.2 GCC Countries

11.6.3 Turkey

11.6.4 Egypt

11.6.5 South Africa

12 Corporate Profile

12.1 Bio-Techne

12.1.1 Bio-Techne Corporation Information

12.1.2 Bio-Techne Business Overview

12.1.3 Bio-Techne Ghrelin Product Models, Descriptions and Specifications

12.1.4 Bio-Techne Ghrelin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.1.5 Bio-Techne Ghrelin Sales by Product in 2024

12.1.6 Bio-Techne Ghrelin Sales by Application in 2024

12.1.7 Bio-Techne Ghrelin Sales by Geographic Area in 2024

12.1.8 Bio-Techne Ghrelin SWOT Analysis

12.1.9 Bio-Techne Recent Developments

12.2 Isca Biochemicals

12.2.1 Isca Biochemicals Corporation Information

12.2.2 Isca Biochemicals Business Overview

12.2.3 Isca Biochemicals Ghrelin Product Models, Descriptions and Specifications

12.2.4 Isca Biochemicals Ghrelin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.2.5 Isca Biochemicals Ghrelin Sales by Product in 2024

12.2.6 Isca Biochemicals Ghrelin Sales by Application in 2024

12.2.7 Isca Biochemicals Ghrelin Sales by Geographic Area in 2024

12.2.8 Isca Biochemicals Ghrelin SWOT Analysis

12.2.9 Isca Biochemicals Recent Developments

12.3 Elabscience Bionovation Inc

12.3.1 Elabscience Bionovation Inc Corporation Information

12.3.2 Elabscience Bionovation Inc Business Overview

12.3.3 Elabscience Bionovation Inc Ghrelin Product Models, Descriptions and Specifications

12.3.4 Elabscience Bionovation Inc Ghrelin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.3.5 Elabscience Bionovation Inc Ghrelin Sales by Product in 2024

12.3.6 Elabscience Bionovation Inc Ghrelin Sales by Application in 2024

12.3.7 Elabscience Bionovation Inc Ghrelin Sales by Geographic Area in 2024

12.3.8 Elabscience Bionovation Inc Ghrelin SWOT Analysis

12.3.9 Elabscience Bionovation Inc Recent Developments

12.4 Life Science Group

12.4.1 Life Science Group Corporation Information

12.4.2 Life Science Group Business Overview

12.4.3 Life Science Group Ghrelin Product Models, Descriptions and Specifications

12.4.4 Life Science Group Ghrelin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.4.5 Life Science Group Ghrelin Sales by Product in 2024

12.4.6 Life Science Group Ghrelin Sales by Application in 2024

12.4.7 Life Science Group Ghrelin Sales by Geographic Area in 2024

12.4.8 Life Science Group Ghrelin SWOT Analysis

12.4.9 Life Science Group Recent Developments

12.5 BioCrick

12.5.1 BioCrick Corporation Information

12.5.2 BioCrick Business Overview

12.5.3 BioCrick Ghrelin Product Models, Descriptions and Specifications

12.5.4 BioCrick Ghrelin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.5.5 BioCrick Ghrelin Sales by Product in 2024

12.5.6 BioCrick Ghrelin Sales by Application in 2024

12.5.7 BioCrick Ghrelin Sales by Geographic Area in 2024

12.5.8 BioCrick Ghrelin SWOT Analysis

12.5.9 BioCrick Recent Developments

12.6 CPC Scientific Inc

12.6.1 CPC Scientific Inc Corporation Information

12.6.2 CPC Scientific Inc Business Overview

12.6.3 CPC Scientific Inc Ghrelin Product Models, Descriptions and Specifications

12.6.4 CPC Scientific Inc Ghrelin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.6.5 CPC Scientific Inc Recent Developments

12.7 Bachem

12.7.1 Bachem Corporation Information

12.7.2 Bachem Business Overview

12.7.3 Bachem Ghrelin Product Models, Descriptions and Specifications

12.7.4 Bachem Ghrelin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.7.5 Bachem Recent Developments

12.8 Merck KGaA

12.8.1 Merck KGaA Corporation Information

12.8.2 Merck KGaA Business Overview

12.8.3 Merck KGaA Ghrelin Product Models, Descriptions and Specifications

12.8.4 Merck KGaA Ghrelin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.8.5 Merck KGaA Recent Developments

12.9 GenScript

12.9.1 GenScript Corporation Information

12.9.2 GenScript Business Overview

12.9.3 GenScript Ghrelin Product Models, Descriptions and Specifications

12.9.4 GenScript Ghrelin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.9.5 GenScript Recent Developments

12.10 Kaneka Corporation(Eurogentec)

12.10.1 Kaneka Corporation(Eurogentec) Corporation Information

12.10.2 Kaneka Corporation(Eurogentec) Business Overview

12.10.3 Kaneka Corporation(Eurogentec) Ghrelin Product Models, Descriptions and Specifications

12.10.4 Kaneka Corporation(Eurogentec) Ghrelin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.10.5 Kaneka Corporation(Eurogentec) Recent Developments

12.11 Biorbyt

12.11.1 Biorbyt Corporation Information

12.11.2 Biorbyt Business Overview

12.11.3 Biorbyt Ghrelin Product Models, Descriptions and Specifications

12.11.4 Biorbyt Ghrelin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.11.5 Biorbyt Recent Developments

12.12 Creative Diagnostics

12.12.1 Creative Diagnostics Corporation Information

12.12.2 Creative Diagnostics Business Overview

12.12.3 Creative Diagnostics Ghrelin Product Models, Descriptions and Specifications

12.12.4 Creative Diagnostics Ghrelin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.12.5 Creative Diagnostics Recent Developments

12.13 AAPPTec, LLC

12.13.1 AAPPTec, LLC Corporation Information

12.13.2 AAPPTec, LLC Business Overview

12.13.3 AAPPTec, LLC Ghrelin Product Models, Descriptions and Specifications

12.13.4 AAPPTec, LLC Ghrelin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.13.5 AAPPTec, LLC Recent Developments

12.14 Cayman Chemical

12.14.1 Cayman Chemical Corporation Information

12.14.2 Cayman Chemical Business Overview

12.14.3 Cayman Chemical Ghrelin Product Models, Descriptions and Specifications

12.14.4 Cayman Chemical Ghrelin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.14.5 Cayman Chemical Recent Developments

13 Value Chain and Supply-Chain Analysis

13.1 Ghrelin Industry Chain

13.2 Ghrelin Upstream Materials Analysis

13.2.1 Raw Materials

13.2.2 Key Suppliers Market Share & Risk Assessment

13.3 Ghrelin Integrated Production Analysis

13.3.1 Manufacturing Footprint Analysis

13.3.2 Production Technology Overview

13.3.3 Regional Cost Drivers

13.4 Ghrelin Sales Channels and Distribution Networks

13.4.1 Sales Channels

13.4.2 Distributors

14 Ghrelin Market Dynamics

14.1 Industry Trends and Evolution

14.2 Market Growth Drivers and Emerging Opportunities

14.3 Market Challenges, Risks, and Restraints

15 Key Findings in the Global Ghrelin Study

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.1.1 Research Programs/Design

16.1.1.2 Market Size Estimation

16.1.1.3 Market Breakdown and Data Triangulation

16.1.2 Data Source

16.1.2.1 Secondary Sources

16.1.2.2 Primary Sources

16.2 Author Details

FEATURED COMPANIES

Bio-Techne

Isca Biochemicals

Elabscience Bionovation Inc.

Kaneka Corporation (Eurogentec)

List of Tables

Table 1. Global Ghrelin Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Ghrelin Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Ghrelin Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Ghrelin Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Ghrelin Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Ghrelin Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (kg)

Table 7. Global Ghrelin Sales by Region (2020-2025) & (kg)

Table 8. Global Ghrelin Sales by Region (2026-2031) & (kg)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Ghrelin Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (kg)

Table 11. Global Ghrelin Production by Region (2020-2025) & (kg)

Table 12. Global Ghrelin Production by Region (2026-2031) & (kg)

Table 13. Global Ghrelin Sales by Manufacturers (2020-2025) & (kg)

Table 14. Global Ghrelin Sales Share by Manufacturers (2020-2025)

Table 15. Global Ghrelin Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 16. Global Ghrelin Revenue Market Share by Manufacturers (2020-2025)

Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 18. Global Ghrelin by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ghrelin as of 2024)

Table 19. Global Ghrelin Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 20. Global Ghrelin Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/g)

Table 21. Key Manufacturers Ghrelin Manufacturing Base and Headquarters

Table 22. Global Ghrelin Market Concentration Ratio (CR5 and HHI)

Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 25. Global Ghrelin Sales by Type (2020-2025) & (kg)

Table 26. Global Ghrelin Sales by Type (2026-2031) & (kg)

Table 27. Global Ghrelin Revenue by Type (2020-2025) & (US$ Million)

Table 28. Global Ghrelin Revenue by Type (2026-2031) & (US$ Million)

Table 29. Global Ghrelin ASP by Type (2020-2031) & (US$/g)

Table 30. Technical Specifications by Key Product Type

Table 31. Global Ghrelin Sales by Application (2020-2025) & (kg)

Table 32. Global Ghrelin Sales by Application (2026-2031) & (kg)

Table 33. Ghrelin High-Growth Sectors Demand CAGR (2024-2031)

Table 34. Global Ghrelin Revenue by Application (2020-2025) & (US$ Million)

Table 35. Global Ghrelin Revenue by Application (2026-2031) & (US$ Million)

Table 36. Global Ghrelin ASP by Application (2020-2031) & (US$/g)

Table 37. Top Customers by Region

Table 38. Top Customers by Application

Table 39. North America Ghrelin Growth Accelerators and Market Barriers

Table 40. North America Ghrelin Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 41. North America Ghrelin Sales (kg) by Country (2020 VS 2024 VS 2031)

Table 42. Europe Ghrelin Growth Accelerators and Market Barriers

Table 43. Europe Ghrelin Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 44. Europe Ghrelin Sales (kg) by Country (2020 VS 2024 VS 2031)

Table 45. Asia-Pacific Ghrelin Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Asia-Pacific Ghrelin Sales (kg) by Country (2020 VS 2024 VS 2031)

Table 47. Asia-Pacific Ghrelin Growth Accelerators and Market Barriers

Table 48. Southeast Asia Ghrelin Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 49. Central and South America Ghrelin Investment Opportunities and Key Challenges

Table 50. Central and South America Ghrelin Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 51. Middle East and Africa Ghrelin Investment Opportunities and Key Challenges

Table 52. Middle East and Africa Ghrelin Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 53. Bio-Techne Corporation Information

Table 54. Bio-Techne Description and Major Businesses

Table 55. Bio-Techne Product Models, Descriptions and Specifications

Table 56. Bio-Techne Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 57. Bio-Techne Sales Value Proportion by Product in 2024

Table 58. Bio-Techne Sales Value Proportion by Application in 2024

Table 59. Bio-Techne Sales Value Proportion by Geographic Area in 2024

Table 60. Bio-Techne Ghrelin SWOT Analysis

Table 61. Bio-Techne Recent Developments

Table 62. Isca Biochemicals Corporation Information

Table 63. Isca Biochemicals Description and Major Businesses

Table 64. Isca Biochemicals Product Models, Descriptions and Specifications

Table 65. Isca Biochemicals Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 66. Isca Biochemicals Sales Value Proportion by Product in 2024

Table 67. Isca Biochemicals Sales Value Proportion by Application in 2024

Table 68. Isca Biochemicals Sales Value Proportion by Geographic Area in 2024

Table 69. Isca Biochemicals Ghrelin SWOT Analysis

Table 70. Isca Biochemicals Recent Developments

Table 71. Elabscience Bionovation Inc Corporation Information

Table 72. Elabscience Bionovation Inc Description and Major Businesses

Table 73. Elabscience Bionovation Inc Product Models, Descriptions and Specifications

Table 74. Elabscience Bionovation Inc Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 75. Elabscience Bionovation Inc Sales Value Proportion by Product in 2024

Table 76. Elabscience Bionovation Inc Sales Value Proportion by Application in 2024

Table 77. Elabscience Bionovation Inc Sales Value Proportion by Geographic Area in 2024

Table 78. Elabscience Bionovation Inc Ghrelin SWOT Analysis

Table 79. Elabscience Bionovation Inc Recent Developments

Table 80. Life Science Group Corporation Information

Table 81. Life Science Group Description and Major Businesses

Table 82. Life Science Group Product Models, Descriptions and Specifications

Table 83. Life Science Group Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 84. Life Science Group Sales Value Proportion by Product in 2024

Table 85. Life Science Group Sales Value Proportion by Application in 2024

Table 86. Life Science Group Sales Value Proportion by Geographic Area in 2024

Table 87. Life Science Group Ghrelin SWOT Analysis

Table 88. Life Science Group Recent Developments

Table 89. BioCrick Corporation Information

Table 90. BioCrick Description and Major Businesses

Table 91. BioCrick Product Models, Descriptions and Specifications

Table 92. BioCrick Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 93. BioCrick Sales Value Proportion by Product in 2024

Table 94. BioCrick Sales Value Proportion by Application in 2024

Table 95. BioCrick Sales Value Proportion by Geographic Area in 2024

Table 96. BioCrick Ghrelin SWOT Analysis

Table 97. BioCrick Recent Developments

Table 98. CPC Scientific Inc Corporation Information

Table 99. CPC Scientific Inc Description and Major Businesses

Table 100. CPC Scientific Inc Product Models, Descriptions and Specifications

Table 101. CPC Scientific Inc Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 102. CPC Scientific Inc Recent Developments

Table 103. Bachem Corporation Information

Table 104. Bachem Description and Major Businesses

Table 105. Bachem Product Models, Descriptions and Specifications

Table 106. Bachem Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 107. Bachem Recent Developments

Table 108. Merck KGaA Corporation Information

Table 109. Merck KGaA Description and Major Businesses

Table 110. Merck KGaA Product Models, Descriptions and Specifications

Table 111. Merck KGaA Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 112. Merck KGaA Recent Developments

Table 113. GenScript Corporation Information

Table 114. GenScript Description and Major Businesses

Table 115. GenScript Product Models, Descriptions and Specifications

Table 116. GenScript Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 117. GenScript Recent Developments

Table 118. Kaneka Corporation(Eurogentec) Corporation Information

Table 119. Kaneka Corporation(Eurogentec) Description and Major Businesses

Table 120. Kaneka Corporation(Eurogentec) Product Models, Descriptions and Specifications

Table 121. Kaneka Corporation(Eurogentec) Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 122. Kaneka Corporation(Eurogentec) Recent Developments

Table 123. Biorbyt Corporation Information

Table 124. Biorbyt Description and Major Businesses

Table 125. Biorbyt Product Models, Descriptions and Specifications

Table 126. Biorbyt Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 127. Biorbyt Recent Developments

Table 128. Creative Diagnostics Corporation Information

Table 129. Creative Diagnostics Description and Major Businesses

Table 130. Creative Diagnostics Product Models, Descriptions and Specifications

Table 131. Creative Diagnostics Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 132. Creative Diagnostics Recent Developments

Table 133. AAPPTec, LLC Corporation Information

Table 134. AAPPTec, LLC Description and Major Businesses

Table 135. AAPPTec, LLC Product Models, Descriptions and Specifications

Table 136. AAPPTec, LLC Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 137. AAPPTec, LLC Recent Developments

Table 138. Cayman Chemical Corporation Information

Table 139. Cayman Chemical Description and Major Businesses

Table 140. Cayman Chemical Product Models, Descriptions and Specifications

Table 141. Cayman Chemical Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 142. Cayman Chemical Recent Developments

Table 143. Key Raw Materials Distribution

Table 144. Raw Materials Key Suppliers

Table 145. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 146. Milestones in Production Technology Evolution

Table 147. Distributors List

Table 148. Market Trends and Market Evolution

Table 149. Market Drivers and Opportunities

Table 150. Market Challenges, Risks, and Restraints

Table 151. Research Programs/Design for This Report

Table 152. Key Data Information from Secondary Sources

Table 153. Key Data Information from Primary Sources

List of Figures

Figure 1. Ghrelin Product Picture

Figure 2. Global Ghrelin Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Mouse Product Picture

Figure 4. Rat Product Picture

Figure 5. Human Product Picture

Figure 6. Global Ghrelin Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 7. Obesity and Weight Management

Figure 8. Gastrointestinal Diseases

Figure 9. Neuroprotection

Figure 10. Other

Figure 11. Ghrelin Report Years Considered

Figure 12. Global Ghrelin Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Ghrelin Revenue (2020-2031) & (US$ Million)

Figure 14. Global Ghrelin Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 15. Global Ghrelin Revenue Market Share by Region (2020-2031)

Figure 16. Global Ghrelin Sales (2020-2031) & (kg)

Figure 17. Global Ghrelin Sales (CAGR) by Region (2020-2031) (kg)

Figure 18. Global Ghrelin Sales Market Share by Region (2020-2031)

Figure 19. Global Ghrelin Capacity, Production and Utilization (2020-2031) & (kg)

Figure 20. Global Ghrelin Production Trend by Region (2020-2031) (kg)

Figure 21. Global Ghrelin Production Market Share by Region (2020-2031)

Figure 22. Production Capacity Enablers & Constraints

Figure 23. Ghrelin Production Growth Rate in North America (2020-2031) & (kg)

Figure 24. Ghrelin Production Growth Rate in Europe (2020-2031) & (kg)

Figure 25. Ghrelin Production Growth Rate in China (2020-2031) & (kg)

Figure 26. Ghrelin Production Growth Rate in Japan (2020-2031) & (kg)

Figure 27. Top 5 and Top 10 Manufacturers Ghrelin Sales Volume Market Share in 2024

Figure 28. Global Ghrelin Revenue Market Share Ranking (2024)

Figure 29. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 30. Mouse Revenue Market Share by Manufacturer in 2024

Figure 31. Rat Revenue Market Share by Manufacturer in 2024

Figure 32. Human Revenue Market Share by Manufacturer in 2024

Figure 33. Type Eight Revenue Market Share by Manufacturer in 2024

Figure 34. Type Nine Revenue Market Share by Manufacturer in 2024

Figure 35. Global Ghrelin Sales Market Share by Type (2020-2031)

Figure 36. Global Ghrelin Revenue Market Share by Type (2020-2031)

Figure 37. Global Ghrelin Sales Market Share by Application (2020-2031)

Figure 38. Global Ghrelin Revenue Market Share by Application (2020-2031)

Figure 39. North America Ghrelin Sales YoY (2020-2031) & (kg)

Figure 40. North America Ghrelin Revenue YoY (2020-2031) & (US$ Million)

Figure 41. North America Top 5 Manufacturers Ghrelin Sales Revenue (US$ Million) in 2024

Figure 42. North America Ghrelin Sales Volume (kg) by Type (2020- 2031)

Figure 43. North America Ghrelin Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 44. North America Ghrelin Sales Volume (kg) by Application (2020-2031)

Figure 45. North America Ghrelin Sales Revenue (US$ Million) by Application (2020-2031)

Figure 46. US Ghrelin Revenue (2020-2031) & (US$ Million)

Figure 47. Canada Ghrelin Revenue (2020-2031) & (US$ Million)

Figure 48. Mexico Ghrelin Revenue (2020-2031) & (US$ Million)

Figure 49. Europe Ghrelin Sales YoY (2020-2031) & (kg)

Figure 50. Europe Ghrelin Revenue YoY (2020-2031) & (US$ Million)

Figure 51. Europe Top 5 Manufacturers Ghrelin Sales Revenue (US$ Million) in 2024

Figure 52. Europe Ghrelin Sales Volume (kg) by Type (2020-2031)

Figure 53. Europe Ghrelin Sales Revenue (US$ Million) by Type (2020-2031)

Figure 54. Europe Ghrelin Sales Volume (kg) by Application (2020-2031)

Figure 55. Europe Ghrelin Sales Revenue (US$ Million) by Application (2020-2031)

Figure 56. Germany Ghrelin Revenue (2020-2031) & (US$ Million)

Figure 57. France Ghrelin Revenue (2020-2031) & (US$ Million)

Figure 58. U.K. Ghrelin Revenue (2020-2031) & (US$ Million)

Figure 59. Italy Ghrelin Revenue (2020-2031) & (US$ Million)

Figure 60. Russia Ghrelin Revenue (2020-2031) & (US$ Million)

Figure 61. Asia-Pacific Ghrelin Sales YoY (2020-2031) & (kg)

Figure 62. Asia-Pacific Ghrelin Revenue YoY (2020-2031) & (US$ Million)

Figure 63. Asia-Pacific Top 8 Manufacturers Ghrelin Sales Revenue (US$ Million) in 2024

Figure 64. Asia-Pacific Ghrelin Sales Volume (kg) by Type (2020- 2031)

Figure 65. Asia-Pacific Ghrelin Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 66. Asia-Pacific Ghrelin Sales Volume (kg) by Application (2020-2031)

Figure 67. Asia-Pacific Ghrelin Sales Revenue (US$ Million) by Application (2020-2031)

Figure 68. Indonesia Ghrelin Revenue (2020-2031) & (US$ Million)

Figure 69. Japan Ghrelin Revenue (2020-2031) & (US$ Million)

Figure 70. South Korea Ghrelin Revenue (2020-2031) & (US$ Million)

Figure 71. China Taiwan Ghrelin Revenue (2020-2031) & (US$ Million)

Figure 72. India Ghrelin Revenue (2020-2031) & (US$ Million)

Figure 73. Central and South America Ghrelin Sales YoY (2020-2031) & (kg)

Figure 74. Central and South America Ghrelin Revenue YoY (2020-2031) & (US$ Million)

Figure 75. Central and South America Top 5 Manufacturers Ghrelin Sales Revenue (US$ Million) in 2024

Figure 76. Central and South America Ghrelin Sales Volume (kg) by Type (2021-2031)

Figure 77. Central and South America Ghrelin Sales Revenue (US$ Million) by Type (2020-2031)

Figure 78. Central and South America Ghrelin Sales Volume (kg) by Application (2020-2031)

Figure 79. Central and South America Ghrelin Sales Revenue (US$ Million) by Application (2020-2031)

Figure 80. Brazil Ghrelin Revenue (2020-2025) & (US$ Million)

Figure 81. Argentina Ghrelin Revenue (2020-2025) & (US$ Million)

Figure 82. Middle East, and Africa Ghrelin Sales YoY (2020-2031) & (kg)

Figure 83. Middle East and Africa Ghrelin Revenue YoY (2020-2031) & (US$ Million)

Figure 84. Middle East and Africa Top 5 Manufacturers Ghrelin Sales Revenue (US$ Million) in 2024

Figure 85. Middle East and Africa Ghrelin Sales Volume (kg) by Type (2021-2031)

Figure 86. South America Ghrelin Sales Revenue (US$ Million) by Type (2020-2031)

Figure 87. Middle East and Africa Ghrelin Sales Volume (kg) by Application (2020-2031)

Figure 88. Middle East and Africa Ghrelin Sales Revenue (US$ Million) by Application (2020-2031)

Figure 89. GCC Countries Ghrelin Revenue (2020-2025) & (US$ Million)

Figure 90. Turkey Ghrelin Revenue (2020-2025) & (US$ Million)

Figure 91. Egypt Ghrelin Revenue (2020-2025) & (US$ Million)

Figure 92. South Africa Ghrelin Revenue (2020-2025) & (US$ Million)

Figure 93. Ghrelin Industry Chain Mapping

Figure 94. Regional Ghrelin Manufacturing Base Distribution (%)

Figure 95. Ghrelin Production Process

Figure 96. Regional Ghrelin Production Cost Structure

Figure 97. Channels of Distribution (Direct Vs Distribution)

Figure 98. Bottom-up and Top-down Approaches for This Report

Figure 99. Data Triangulation

Figure 100. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-3V17938

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Corticosteroid Allergy Nasal Spray Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-18T17751

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Pioglitazone Hydrochloride Capsules Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-10K20152

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Peripheral Vascular Support Catheter Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-14O17929

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Ghrelin Market Outlook, In‑Depth Analysis & Forecast to 2031

Published Date: October 2025

Report Code: QYRE-Auto-13F20093

Global Ghrelin Market Outlook, In‑Depth Analysis & Forecast to 2031

FEATURED COMPANIES

Ghrelin Market

Report Includes:

Scope of Ghrelin Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Ghrelin Market report?

What are the Application segmentation covered in the Ghrelin Market report?

What are the Type segmentation covered in the Ghrelin Market report?

FEATURED COMPANIES

RELATED REPORTS